ABSTRACT

Previous science stage: Video assisted thoracoscopic surgery (VATS) permit to perform important number of thoracic surgery with efficiency and security. It is reinforce up to literature review. Methods: We performed retrospective investigation in the National Centre for Endoscopic Surgery, in Havana, Cuba. The period in study included operated patients from 2003 to 2010. They were 327 patients. Informatics software to recollect variable in study, were take in consideration. SPSS for Windows 10.0 helped us to realize relevant statistical inference. Results: For all of these interventions: 54 and 273 were doing with diagnostics and therapeutics end respectively. From therapeutics surgeries: 55 pleurectomies, 120 simpathectomy, 29 non regular lung resection, 26 pleural effusion, 19 transthoracic vaguectomy, 14 mediastinal tumors resections, 9 pericardics windows, 2 malignant pleural mesotelioma and 2 mayor lung resections. Surgical time was 65 minutes as medial record. Drainage was used in 65% of patients with 36 hours as medial demurrage. We use prophylactics antibiotics in 37% and 0.9% of patient needed conventional antibiotic therapy. The 62.1% of patients do not use antibiotics. As complications we had 65 patients with subcutaneus emphysema and local port infections in 3 patients (0.9%). Only one of these patients needed to be operated again duo to massive hemorrhage and died two hours after that. Conclusions: Thoracoscopic approach permits to treat an important number and different diseases. Excellent security and efficiency, less complication, pain and better cosmetic post operatory appearance are the principle characteristics of this specifics access.

KEYWORDS

Video assisted thoracoscopic surgery, efficiency, minor aggression, security.

REFERENCES

1. Yamamoto K, Ohsumi A, Kojima F, et al. Long-term survival after video-assisted thoracic surgery lobectomy for primary lung cancer. Ann Thorac Surg 2010;89:353-359.

2. Borro JM, Moreno R, Gómez A, Duque JL. Cirugía torácica videoasistida, trasplante pulmonar y mediastinitis, temas destacados de cirugía torácica en 2010. Arch Bronconeumol 2011;47(Supl 1):12-15.

3. Khorsandi M, Shaikhrezai K, Wallace W, Brackenbury E. Is fine-needle aspiration diagnosis of malignancy adequate prior to major lung resections including pneumonectomy? Interact Cardiovasc Thorac Surg 2012;15:253-257.

4. Jones RO, Casali G, Walker WS. Does failed video-assisted lobectomy for lung cancer prejudice immediate and long-term outcomes? Ann Thorac Surg 2008;86:235-239.

5. Cho S, Do YW, Lee EB. Comparison of costs for video-assisted thoracic surgery lobectomy and open lobectomy for non-small cell lung cancer. Surg Endosc 2011;25:1054-1061.

6. Boffa DJ, Kosinski AS, Paul S, Mitchell JD, Onaitis M. Lymph node evaluation by open or video-assisted approaches in 11,500 anatomic lung cancer resections. Ann Thorac Surg 2012;94:347-353.

7. Yan TD, Black D, Bannon PG, McCaughan BC. Systematic review and meta-analysis of randomized and nonrandomized trials on safety and efficacy of video-assisted thoracic surgery lobectomy for early-stage non-small-cell lung cancer. J Clin Oncol 2009;27:2553-2562.

8. Axelsson TA, Sigurdsson MI, Alexandersson A, et al. Intensive care unit admissions following lobectomy or sublobar resections for non-small cell lung cancer. Laeknabladid 2012;98:271-275.

9. Thorsteinsson H, Alexandersson A, Oskarsdottir GN, et al. Resection rate and outcome of pulmonary resections for non-small-cell lung cancer: a nationwide study from Iceland. J Thorac Oncol 2012;7:1164-1169.

10. Petrella F, Radice D, Borri A, et al. The impact of preoperative body mass index on respiratory complications after pneumonectomy for non-small-cell lung cancer. Results from a series of 154 consecutive standard pneumonectomies. Eur J Cardiothorac Surg 2011;39:738-744.

11. Bradley JD, Bae K, Graham MV, et al. Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117. J Clin Oncol 2010;28:2475-2480.